ADA and cancer: Previously, we have reported that adenosine-converting ecto-enzyme, which is a cell surface adenosine deaminase (ADA), may serve as a biomarker of endothelial activation and vascular inflammation in cardiovascular pathologies [15], neurodegeneration [16], and cancer [17].